Gliotoxin from Gliocladium fimbriatum
SIGMA/G9893
Synonym: Aspergillin
CAS Number: 67-99-2
Empirical Formula (Hill Notation): C13H14N2O4S2
Molecular Weight: 326.39
MDL Number: MFCD00058534
Linear Formula: C13H14N2O4S2
Product Type: Chemical
| antibiotic activity spectrum | viruses |
| InChI | 1S/C13H14N2O4S2/c1-14-10( |
| InChI key | FIVPIPIDMRVLAY-RBJBARPLSA |
| mode of action | DNA synthesis | interferes |
| enzyme | inhibits | |
| Quality Level | 200 ![]() |
| SMILES string | CN1C(=O)[C@]23CC4=CC=C[C@ |
| storage temp. | 2-8°C |
| Application: | Gliotoxin has been used for performing cytotoxicity tests in adenocarcinomic human alveolar basal epithelial (A549) cell lines. |
| Application: | Noncompetitive inhibitor of the chymotrypsin-like activity of the 20S proteasome in vitro. |
| Biochem/physiol Actions: | Gliotoxin is associated with immunosuppression. It is an antiphagocytic and immunomodulating agent that acts by blocking membrane thiol groups. It is implicated in the pathophysiology of invasive aspergillosis (IA) and impacts functional T-cell responses. Gliotoxin in observed in the sera of cancer patients with IA infection. |
| General description: | Chemical structure: epipolythiodioxopiperazin |
| General description: | Gliotoxin is the mycotoxin produced by Aspergillus fumigatus (AF). It is a hydrophobic metabolite of 326 Da. |
| Packaging: | 5, 25 mg in serum bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 36/37/39-45 |
| RIDADR | UN 3462 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


